(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-4,5-二羟基-2-(((2'R,4S,5'R,6aR,6bS,8aR,8bR,9S,11aS,12aR,12bR)-12a-羟基-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚[2,1-b]呋喃-10,2'-吡喃]-4-氧基))-6-(羟甲基)四氢-2H-吡喃-3-氧基))-6-甲基四氢-2H-吡喃-3,4,5-三醇
(3β,25R)-14-Hydroxyspirost-5-en-3-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside (ACI)
产品编号 :
Cas No. :
标准英文名 :
分子式 :
分子量 :
MDL No. :
| 包装规格 | 交货周期 | 质量标准 | 品牌 | 目录价 | 会员专享价 | 数量 |
|---|---|---|---|---|---|---|
|
抱歉，暂无牌价信息 |
||||||
基础信息
| GHS | |
|---|---|
| Smiles | O[C@]12[C@]3([H])CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)CC[C@]4(C)[C@@]3([H])CC[C@@]1([C@@]1([H])[C@H](C)[C@]3(OC[C@H](C)CC3)O[C@@]1([H])C2)C |
| Inchi | InChI=1S/C39H62O13/c1-18-8-13-39(47-17-18)19(2)27-25(52-39)15-38(46)24-7-6-21-14-22(9-11-36(21,4)23(24)10-12-37(27,38)5)49-35-33(31(44)29(42)26(16-40)50-35)51-34-32(45)30(43)28(41)20(3)48-34/h6,18-20,22-35,40-46H,7-17H2,1-5H3/t18-,19+,20+,22+,23+,24-,25+,26-,27+,28+,29-,30-,31+,32-,33-,34+,35-,36+,37-,38-,39-/m1/s1 |
| InchiKey | NSZNCLIIQOMCSO-PSXMPFNDSA-N |
| 别名 | |
| 性状 | |
| 存储条件 | |
| 熔点 | |
| 闪点 | |
| 化学稳定性 | |
| 沸点 | |
| 密度 | |
| 海关编码 | |
| 手性 | |
| 生物活性 | |
| 理化性质 | |
| UN No. | |
| 特性 | |
| 用途 | |
| 蒸气压 | |
| 运输要求 | |
| 品牌 |
安全信息
| 危险类别码 | |
|---|---|
| 信号词 | |
| 水溶解性 | |
| 危险品分类 | |
| 安全说明 | |
| 存储要求 | |
| 危险品标志 | |
| 有害分解物 |
产品介绍
抱歉，暂无产品详情
相关文献
抱歉，暂无相关文献
![2-[3-[[4-(4-Methoxyphenyl)-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]propyl]-1H-benz[de]isoquinoline-1,3(2H)-dione (ACI)](/image/product/78691.png?ts=1784672920)
![8-Fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-4(3H)-quinazolinone (ACI)](/image/product/50078269.png?ts=1784672919)
![Immunoglobulin G4 [230-proline], anti-(human leukocyte Ig-like receptor B4) (human-Mus musculus monoclonal A197U γ4-chain), disulfide with human-Mus musculus monoclonal A197U κ-chain, dimer (ACI)](/image/product/20078355.png?ts=1784672913)
![Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human CD161 antigen) (human monoclonal IMT-009 γ1-chain), disulfide with human monoclonal IMT-009 κ-chain, dimer (ACI)](/image/product/80078305.png?ts=1784672913)
![5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one (ACI)](/image/product/50078253.png?ts=1784672910)
![5,11-Dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one (ACI)](/image/product/90079040.png?ts=1784672910)
![(2R)-2-[3-(3,7-Dimethyl-2,6-octadien-1-yl)-4-hydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one (ACI)](/image/product/30078772.png?ts=1784672903)
![[4-(4-Methoxyphenyl)-1-piperazinyl][1-phenyl-3-(2-thienyl)-1H-pyrazol-4-yl]methanone (ACI)](/image/product/60078716.png?ts=1784672329)
![Immunoglobulin G1 [251-tyrosine,253-threonine,255-glutamic acid], anti-(human interleukin 21) human-Mus musculus monoclonal BOS161721 γ1-chain), disulfide with human-Mus musculus monoclonal BOS161721 κ-chain, dimer (ACI)](/image/product/10079190.png?ts=1784672275)
![Immunoglobulin G4 [227-proline], anti-(human lymphocyte activation gene-3) (human-Mus musculus monoclonal C88 γ4-chain), disulfide with human-Mus musculus monoclonal C88 κ-chain, dimer (ACI)](/image/product/60078755.png?ts=1784672271)
